miR-216b-5p | |||||||
---|---|---|---|---|---|---|---|
Total cases | High expression (n = 37) | Low expression (n = 58) | χ2 | P | |||
n | n | % | n | % | |||
Age (year) | 0.074 | 0.786 | |||||
Postmenopausal(< 50) | 42 | 17 | 40.48 | 25 | 59.52 | ||
Premenopausal (≧50) | 53 | 20 | 37.74 | 33 | 62.26 | ||
Tumor stage (FIGO) | 2.708 | 0.258 | |||||
I-II | 21 | 8 | 38.10 | 13 | 61.90 | ||
III | 45 | 21 | 46.67 | 24 | 53.33 | ||
IV | 29 | 8 | 27.59 | 21 | 72.41 | ||
Histological grade (n = 88) | 2.216 | 0.137 | |||||
H | 72 | 26 | 36.11 | 46 | 63.89 | ||
L | 16 | 9 | 56.25 | 7 | 43.75 | ||
Nodal status (n) | 2.509 | 0.113 | |||||
Negative | 60 | 27 | 45.00 | 33 | 55.00 | ||
Positive | 35 | 10 | 28.57 | 25 | 71.43 | ||
Tumor diameter (cm) | 1.065 | 0.587 | |||||
< 10 cm | 30 | 11 | 36.67 | 19 | 63.33 | ||
10–20 cm | 58 | 22 | 37.93 | 36 | 62.07 | ||
> 20 cm | 7 | 4 | 57.12% | 3 | 42.88 | ||
Chemotherapy | 14.194 | 0.0001 | |||||
Chemoresistance | 32 | 4 | 12.50 | 28 | 87.50 | ||
Chemosensitivity | 63 | 33 | 52.38 | 30 | 47.62 | ||
Metastasis | 0.1 | 0.752 | |||||
Y | 19 | 8 | 42.11 | 11 | 57.89 | ||
N | 76 | 29 | 38.16 | 47 | 61.84 |